We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Reinsurance Group Hits 52-Week High on Solid Q2 Earnings
Read MoreHide Full Article
On Aug 23, 2016, shares of Reinsurance Group of America Inc. (RGA - Free Report) hit a 52-week high of $103.60, driven by strong second-quarter 2016 results. About 0.2 million shares exchanged hands in the last trading session and the stock finally closed at $103.30, up 1.08%. Year to date, the stock has returned 20.75%, which is better than 6.99% returned by the S&P 500.
Reinsurance Group’s operating income of $2.80 per share outperformed the Zacks Consensus Estimate by 22.7%. The bottom line also improved 44% from the prior-year quarter. Better results in the Canada segment owing to favorable mortality, consistent momentum in the U.S. Asset-Intensive business and robust performance in the Asia Pacific drove the upside. This Zacks Rank #3 (Hold) life insurer delivered positive surprises in two of the last four quarters, with an average beat of 3.6%.
Total revenue of the company improved, primarily due to higher premiums. Further, rise in the life insurer’s net premium came on the back of organic growth and in-force transactions.
Reinsurance Group continues to benefit from a mix of organic and transactional opportunities. In addition, the company is poised to benefit from an improving life reinsurance pricing environment.
The company has been displaying a well-balanced execution of its capital management strategy through share buybacks and some small in-force transactions. In keeping with this, the company bought back 11 million shares in the second quarter and currently has $280 million remaining under its share repurchase authorization. With excess capital of around $1 billion, the company has been able to maintain its financial flexibility, which will allow it to continue healthy capital management, thereby boosting profitability.
Notably, the life insurer increased quarterly dividend by 11% to 41 cents in the reported quarter.
Based on the robust second-quarter earnings performance, the Zacks Consensus Estimate also moved north as most of the estimates were revised higher over the last 30 days. The same increased 5.8% to $9.45 for 2016 and inched up 0.2% to $9.82 for 2017.
Some better-ranked stocks from the same space include Health Insurance Innovations, Inc. , Genworth Financial, Inc. (GNW - Free Report) and Primerica, Inc. (PRI - Free Report) . While Health Insurance Innovations sports a Zacks Rank #1 (Strong Buy), both Genworth Financial and Primerica hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Reinsurance Group Hits 52-Week High on Solid Q2 Earnings
On Aug 23, 2016, shares of Reinsurance Group of America Inc. (RGA - Free Report) hit a 52-week high of $103.60, driven by strong second-quarter 2016 results. About 0.2 million shares exchanged hands in the last trading session and the stock finally closed at $103.30, up 1.08%. Year to date, the stock has returned 20.75%, which is better than 6.99% returned by the S&P 500.
Reinsurance Group’s operating income of $2.80 per share outperformed the Zacks Consensus Estimate by 22.7%. The bottom line also improved 44% from the prior-year quarter. Better results in the Canada segment owing to favorable mortality, consistent momentum in the U.S. Asset-Intensive business and robust performance in the Asia Pacific drove the upside. This Zacks Rank #3 (Hold) life insurer delivered positive surprises in two of the last four quarters, with an average beat of 3.6%.
Total revenue of the company improved, primarily due to higher premiums. Further, rise in the life insurer’s net premium came on the back of organic growth and in-force transactions.
Reinsurance Group continues to benefit from a mix of organic and transactional opportunities. In addition, the company is poised to benefit from an improving life reinsurance pricing environment.
The company has been displaying a well-balanced execution of its capital management strategy through share buybacks and some small in-force transactions. In keeping with this, the company bought back 11 million shares in the second quarter and currently has $280 million remaining under its share repurchase authorization. With excess capital of around $1 billion, the company has been able to maintain its financial flexibility, which will allow it to continue healthy capital management, thereby boosting profitability.
Notably, the life insurer increased quarterly dividend by 11% to 41 cents in the reported quarter.
Based on the robust second-quarter earnings performance, the Zacks Consensus Estimate also moved north as most of the estimates were revised higher over the last 30 days. The same increased 5.8% to $9.45 for 2016 and inched up 0.2% to $9.82 for 2017.
REINSURANCE GRP Price and Consensus
REINSURANCE GRP Price and Consensus | REINSURANCE GRP Quote
Stocks to Consider
Some better-ranked stocks from the same space include Health Insurance Innovations, Inc. , Genworth Financial, Inc. (GNW - Free Report) and Primerica, Inc. (PRI - Free Report) . While Health Insurance Innovations sports a Zacks Rank #1 (Strong Buy), both Genworth Financial and Primerica hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>